News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
607,731 Results
Type
Article (49855)
Company Profile (236)
Press Release (557630)
Multimedia
Podcasts (130)
Webinars (19)
Section
Business (160025)
Career Advice (3092)
Deals (29044)
Drug Delivery (114)
Drug Development (78792)
Employer Resources (182)
FDA (14569)
Job Trends (12713)
News (287433)
Policy (27852)
Tag
Academia (2507)
Academic (1)
Accelerated approval (16)
Adcomms (31)
Allergies (109)
Alliances (42927)
ALS (137)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (253)
Approvals (14659)
Artificial intelligence (412)
Autoimmune disease (80)
Automation (24)
Bankruptcy (255)
Best Places to Work (10371)
BIOSECURE Act (19)
Biosimilars (143)
Biotechnology (168)
Bladder cancer (136)
Brain cancer (51)
Breast cancer (514)
Cancer (4031)
Cardiovascular disease (279)
Career advice (2618)
Career pathing (37)
CAR-T (240)
CDC (34)
Cell therapy (616)
Cervical cancer (33)
Clinical research (65723)
Collaboration (1280)
Company closure (4)
Compensation (777)
Complete response letters (54)
COVID-19 (2643)
CRISPR (69)
C-suite (480)
Cystic fibrosis (127)
Data (4465)
Decentralized trials (1)
Denatured (31)
Depression (101)
Diabetes (365)
Diagnostics (6059)
Digital health (31)
Diversity (10)
Diversity, equity & inclusion (42)
Drug discovery (187)
Drug pricing (147)
Drug shortages (22)
Duchenne muscular dystrophy (170)
Earnings (66859)
Editorial (51)
Employer branding (25)
Employer resources (158)
Events (96679)
Executive appointments (792)
FDA (16851)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (1085)
Gene editing (148)
Generative AI (35)
Gene therapy (468)
GLP-1 (866)
Government (4632)
Grass and pollen (7)
Guidances (333)
Healthcare (16920)
HIV (41)
Huntington's disease (35)
IgA nephropathy (59)
Immunology and inflammation (201)
Immuno-oncology (19)
Indications (53)
Infectious disease (2859)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (93)
Intellectual property (178)
Interviews (622)
IPO (14681)
IRA (43)
Job creations (2692)
Job search strategy (2116)
Kidney cancer (16)
Labor market (71)
Layoffs (458)
Leadership (36)
Legal (5274)
Liver cancer (92)
Longevity (10)
Lung cancer (584)
Lymphoma (265)
Machine learning (29)
Management (63)
Manufacturing (516)
MASH (129)
Medical device (10484)
Medtech (10498)
Mergers & acquisitions (15213)
Metabolic disorders (994)
Multiple sclerosis (131)
NASH (23)
Neurodegenerative disease (197)
Neuropsychiatric disorders (52)
Neuroscience (2398)
NextGen: Class of 2025 (5744)
Non-profit (4107)
Now hiring (54)
Obesity (468)
Opinion (287)
Ovarian cancer (137)
Pain (137)
Pancreatic cancer (176)
Parkinson's disease (215)
Partnered (24)
Patents (371)
Patient recruitment (312)
Peanut (46)
People (44613)
Pharmaceutical (62)
Pharmacy benefit managers (21)
Phase I (20798)
Phase II (29035)
Phase III (21532)
Pipeline (2614)
Policy (233)
Postmarket research (2283)
Preclinical (8947)
Press Release (52)
Prostate cancer (204)
Psychedelics (44)
Radiopharmaceuticals (274)
Rare diseases (609)
Real estate (4212)
Recruiting (76)
Regulatory (21191)
Reports (48)
Research institute (2355)
Resumes & cover letters (499)
Rett syndrome (16)
RNA editing (12)
RSV (62)
Schizophrenia (131)
Series A (179)
Series B (131)
Service/supplier (10)
Sickle cell disease (74)
Special edition (26)
Spinal muscular atrophy (146)
Sponsored (36)
Startups (3097)
State (2)
Stomach cancer (17)
Supply chain (76)
Tariffs (73)
The Weekly (97)
Vaccines (920)
Venture capital (60)
Weight loss (320)
Women's health (49)
Worklife (21)
Date
Today (130)
Last 7 days (604)
Last 30 days (2400)
Last 365 days (28869)
2025 (23424)
2024 (33237)
2023 (37849)
2022 (48388)
2021 (52204)
2020 (50069)
2019 (41752)
2018 (31647)
2017 (29666)
2016 (28361)
2015 (33079)
2014 (25140)
2013 (20527)
2012 (21173)
2011 (21721)
2010 (19875)
Location
Africa (826)
Alabama (67)
Alaska (6)
Arizona (158)
Arkansas (10)
Asia (40760)
Australia (6867)
California (8561)
Canada (2771)
China (860)
Colorado (345)
Connecticut (368)
Delaware (262)
Europe (83943)
Florida (1234)
Georgia (273)
Hawaii (2)
Idaho (43)
Illinois (621)
India (42)
Indiana (400)
Iowa (17)
Japan (315)
Kansas (108)
Kentucky (27)
Louisiana (16)
Maine (74)
Maryland (1138)
Massachusetts (6312)
Michigan (251)
Minnesota (408)
Mississippi (3)
Missouri (104)
Montana (30)
Nebraska (18)
Nevada (93)
New Hampshire (62)
New Jersey (2441)
New Mexico (24)
New York (2378)
North Carolina (1119)
North Dakota (7)
Northern California (4013)
Ohio (241)
Oklahoma (14)
Oregon (35)
Pennsylvania (1691)
Puerto Rico (14)
Rhode Island (28)
South America (1047)
South Carolina (44)
Southern California (3306)
Tennessee (102)
Texas (1326)
United States (30730)
Utah (244)
Virginia (207)
Washington D.C. (64)
Washington State (730)
West Virginia (3)
Wisconsin (76)
607,731 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
September 15, 2025
·
6 min read
Press Releases
Can-Fite Reports H1 2025 Financial Results and Clinical Update
August 29, 2025
·
11 min read
Career Advice
Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews
Media coverage can help biopharma executives connect with, inform and inspire the public. In this column, Kaye/Bassman’s Michael Pietrack and three communications experts share how to make the most of these opportunities.
August 20, 2025
·
6 min read
·
Michael Pietrack
Press Releases
Can-Fite Announces Up To $15.0 Million Public Offering
July 29, 2025
·
6 min read
Press Releases
Breakthrough Study from UCLA Demonstrate Can-Fite’s Piclidenoson as a Treatment for Vascular Dementia
July 29, 2025
·
5 min read
Press Releases
Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone
July 31, 2025
·
5 min read
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
Can-Fite BioPharma Ltd. announces that its VP of Business Development, Dr. Sari Fishman, will hold 23 partnering meetings with Biotech & Pharma companies, who showed interest in partnering with Can-Fite.
May 27, 2024
·
5 min read
Drug Development
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
Can-Fite BioPharma Ltd. today announced an update on the status of its oncological lead drug candidate, Namodenoson in the treatment of advanced liver cancer.
June 5, 2024
·
6 min read
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6
Can-Fite BioPharma Ltd. is pleased to invite investors to a webinar on June 6, 2024, at 4:15 p.m. ET.
May 23, 2024
·
5 min read
Press Releases
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
February 5, 2025
·
5 min read
1 of 60,774
Next
